Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
BioPheresis
company
About
BioPheresis Technologies, a biotech company based in Heidelberg, Germany, offers a blood treatment system designed for cancer cure.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $8M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2003
- Number Of Employee
- 1 - 10
- Operating Status
- Active
BioPheresis Technologies is a US Delaware corporation, and its wholly owned operating company, BioPheresis GmbH, incorporated in 2003, is located in Heidelberg, Germany. BioPheresis has developed a new patent protected blood treatment system designed to remove specific cancer-protecting immune-inhibitors from the blood.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$8M
BioPheresis has raised a total of
$8M
in funding over 2 rounds. Their latest funding was raised on
May 13, 2005 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 13, 2005 | Series A | $8M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
BioPheresis is funded by 1 investors.
firstVentury Equity
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
